Literature DB >> 12681359

Alteration in the expression of early stage processing enzymes of N-glycan during myeloid and monocytoid differentiation of HL-60 cells.

Jia-Hong Zhao1, Ying Zhang, Xia-Ying Zhang, Hui-Li Chen.   

Abstract

The expressions of the enzymes participating in the early stage of N-glycan processing, Golgi alpha-Mase-I, alpha-Mase-II and GnT-I, GnT-II, were studied before and after HL-60 cells were differentiated to myelocytes or monocytes induced by ATRA or PMA, respectively. It was found that alpha-Mase-I activity and GnT-I mRNA were decreased by both ATRA and PMA, while alpha-Mase-II and GnT-II were altered insignificantly. The down-regulation of alpha-Mase-I and GnT-I was cell specific, since ATRA up-regulated alpha-Mase-I and GnT-I in the H7721 hepatocarcinoma cell line. However, in H7721 cells, PMA also decreased alpha-Mase-I and GnT-I, and both ATRA and PMA also did not obviously change the expressions of alpha-Mase-II and GnT-II.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12681359     DOI: 10.1016/s0145-2126(02)00226-6

Source DB:  PubMed          Journal:  Leuk Res        ISSN: 0145-2126            Impact factor:   3.156


  3 in total

1.  Expression of β1,3-N-acetylglucosaminyltransferases during differentiation of human acute myeloid leukemia cells.

Authors:  Hao Qiu; Shi-Liang Wu; Xiang-Hong Guo; Hong-Jie Shen; Huan-Ping Zhang; Hui Li Chen
Journal:  Mol Cell Biochem       Date:  2011-07-01       Impact factor: 3.396

2.  Expressions of polypeptide: N-acetylgalactosaminyltransferase in leukemia cell lines during 1,25-dihydroxyvitamin D3 induced differentiation.

Authors:  Hao Qiu; Xiang-Hong Guo; Jian-Hua Mo; Mei-Fang Jin; Shi-Liang Wu; Hui-Li Chen
Journal:  Glycoconj J       Date:  2006-11       Impact factor: 2.916

3.  Relations of the type and branch of surface N-glycans to cell adhesion, migration and integrin expressions.

Authors:  Ying Zhang; Jia-hong Zhao; Xia-ying Zhang; Hua-bei Guo; Fei Liu; Hui-li Chen
Journal:  Mol Cell Biochem       Date:  2004-05       Impact factor: 3.396

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.